| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Serge Novovich last filed a Form 4 in February 2016, as Director at IRMD. Serge Novovich's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 104,636 shares of IRMD. The IRMD filings lean toward selling, a net 5,010 shares.
Serge Novovich has 6 Form 4 filings on record from August 2015 to February 2016, all as Director at Iradimed (IRMD), 2015–2016.
The 11 reported transactions were 6 open-market sales, 3 stock awards, 1 option or other derivative award and 1 option exercise.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $111K.
The largest open-market sale was 2,910 shares of IRMD at an average $17.23 on February 19, 2016, about $50K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2016 | IRMD Iradimed Corp | Director | Sale+OE | 2,910 | $17.23 | $50,132.02 | -2.7% | |
| Dec 1, 2015 | IRMD Iradimed Corp | Director | Sale+OE | 1,000 | $31.12 | $31,122.90 | -1.0% | |
| Nov 5, 2015 | IRMD Iradimed Corp | Director | Sale+OE | 500 | $30.86 | $15,430.85 | -0.5% | |
| Sep 8, 2015 | IRMD Iradimed Corp | Director | Sell | 600 | $24.67 | $14,800.00 | -13.7% |